netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Dabrafenib found 10 matches
Open monograph to display formulary status BNF Category
  Dabrafenib  (Tafinlar®) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA321: Dabrafenib for treating unresectable or metastatic BRAF V600 mutation‑positive melanoma (08.01.05)
link in drug section NICE TA396: Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma (08.01.05)
link in drug section NICE TA396: Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma (08.01.05)
link in drug section NICE TA544: Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma (08.01.05)
link in drug section NICE TA544: Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma (08.01.05)
link in drug section NICE TA898: Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer (08.01.05)
link in drug section NICE TA898: Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer (08.01.05)
link in drug section NICE TA977: Dabrafenib with trametinib for treating BRAF V600E mutation-positive glioma in children and young people aged 1 year and over (08.01.05)
link in drug section NICE TA977: Dabrafenib with trametinib for treating BRAF V600E mutation-positive glioma in children and young people aged 1 year and over (08.01.05)


 
netFormulary